Skip to main content
About
Contact
Subscribe
e-Edition
Make Home Page
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Twitter
Toggle navigation
Site search
Search
Home
Contact Us
Advertise
Subscription Services
Promote Your Event
Submission Forms
News
Local News
National
World
Archives
Sports
Local Sports
National Sports
Business
Local Business
National Business
Technology
Markets & Stocks
Opinion
Columns
Editorials
Letters To The Editor
Polls
Thumbs
A & E
Local Entertainment
Art Scene
Music Scene
Theatre Scene
Book Reviews
Movie Reviews
TV Listings
Local Events
What To Do
Life
Health
Travel
Oddities
Community Directory
Community Service
Rescue Me
Other
Specials
Spring Home & Garden Show
Home & Realty
Outdoor Guide
Women
Fall Home Improvement
Spring Wellness
Classifieds
Place Ad
Careers
Tenders
Weather
Obituaries
2024 Auction
2024 Readersâ Choice Awards
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about EDIT
Recent news which mentions EDIT
< Previous
1
2
3
4
5
6
7
Next >
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Tickers
ABUS
ACAD
ACIU
ADAP
Tags
PFE
VIR
ADAP
From
Benzinga
Should You Scoop Up Shares of This Promising Biotech on the Dip?
October 28, 2021
Tickers
EDIT
Tags
Market News
EDIT
From
Motley Fool
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
October 21, 2021
Tickers
ABEO
ADMA
BHC
BMY
Tags
RNLX
IPOs
JNJ
From
Benzinga
Editas Medicine Could Skyrocket if Its Gene Editing Therapy Proves Successful
October 19, 2021
Tickers
EDIT
NTLA
Tags
NTLA
Hot Stocks
NASDAQ:EDIT,NASDAQ:NTLA
From
InvestorPlace
Analyst Ratings For Editas Medicine
October 19, 2021
Tickers
EDIT
Tags
BZI/AAR
Analyst Ratings
Benzinga
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 19, 2021
October 19, 2021
Tickers
ACI
ALB
ARBE
ARGX
Tags
EPD
CRSP
CHDN
From
Benzinga
2 Tricks and a Treat for Gene Therapy Investors
October 18, 2021
Tickers
ALPMF
BLUE
CRSP
EDIT
Tags
IBB
VRTX
RGEN
From
Motley Fool
Have $500? This Under-the-Radar Stock Could Make You Richer From the Biotech Boom
October 15, 2021
Tickers
BLFS
EDIT
LZAGF
MRNA
Tags
Market News
EDIT
NTLA
From
Motley Fool
What's Hot in the Stock Market?
October 11, 2021
Tickers
AMZN
ATRO
BBBY
DLTR
Tags
GOOG
DLTR
SHW
From
Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
October 08, 2021
Tickers
AGRX
ALLO
CCXI
CLLS
Tags
AGRX
LTRN
Markets
From
Benzinga
3 Spooky Healthcare Stocks I Would Avoid in October
October 07, 2021
Tickers
BKD
EDIT
JNJ
MRNA
Tags
MRNA
JNJ
BKD
From
Motley Fool
52 Biggest Movers From Yesterday
September 30, 2021
Tickers
ABVC
ACY
AGIL
ALT
Tags
ACY
MIGI
Markets
From
Benzinga
4 Top Stock Trades for Thursday: LCID, DKNG, DLTR, EDIT
September 29, 2021
Tickers
DKNG
DLTR
EDIT
LCID
Tags
LCID
DLTR
Market News
From
InvestorPlace
LSPD Stock: Why This Analyst Report Predicts Up to 80% Downside for Lightspeed Commerce
September 29, 2021
Tickers
EDIT
LSPD
PALT
Tags
LSPD
NYSE:LSPD,NASDAQ:EDIT,NASDAQ:PALT
PALT
From
InvestorPlace
EDIT Stock Is Plunging 20%. Here’s the Gene-Editing News Dragging It Down.
September 29, 2021
Tickers
EDIT
Tags
Market News
EDIT
NASDAQ:EDIT
From
InvestorPlace
PreMarket Prep Stock Of The Day: Editas Medicine
September 29, 2021
Tickers
EDIT
Tags
News
Market News
EDIT
From
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
September 29, 2021
Tickers
ALT
BPTS
DRMA
EDIT
Tags
BPTS
SNOA
EDIT
From
Benzinga
Here's Why Editas Stock Dropped After Data From CRISPR-Based Retinal Disorder Candidate
September 29, 2021
Tickers
EDIT
Tags
Biotech
EDIT
Market News
From
Benzinga
Why Shares of Editas Medicine Are Lower This Morning
September 29, 2021
Tickers
EDIT
NTLA
REGN
Tags
Market News
EDIT
REGN
From
Motley Fool
The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug
September 29, 2021
Tickers
ABBV
ADXN
AGTC
AKYA
Tags
CNTA
Penny Stocks
GBS
From
Benzinga
Breaking Down CRISPR Technology
September 28, 2021
Tickers
BEAM
CRBU
CRSP
EDIT
Tags
NTLA
REGN
Market News
From
Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For September 24, 2021
September 24, 2021
Tickers
ACHC
AEM
ALLO
ALV
Tags
EDIT
Upgrades
Market News
From
Benzinga
Why Cathie Wood Is Buying 2 Gene-Editing Stocks but Selling Another
September 23, 2021
Tickers
ARKG
ARKK
BEAM
CLLS
Tags
NTLA
ARKK
Market News
From
Motley Fool
Buying This Beaten-Down ETF Could Double Your Money Over the Next 5 Years
September 23, 2021
Tickers
DMTK
EDIT
IBB
MRNA
Tags
TWST
DMTK
XBI
From
Motley Fool
3 Moonshot Stocks Hidden in Cathie Wood’s Portfolios
September 22, 2021
Tickers
AMZN
ARKK
CNDT
COIN
Tags
COIN
SKLZ
GSKY
From
InvestorPlace
7 Gene Editing Stocks Promising to Change our DNA
September 15, 2021
Tickers
BAC
BEAM
BLUE
CLLS
Tags
Hot Stocks
REGN
BEAM
From
InvestorPlace
'Fast Money Halftime Report' Picks For September 13
September 13, 2021
Tickers
DKS
EDIT
ORCL
SYK
Tags
CNBC
Media
SYK
From
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 10, 2021
September 10, 2021
Tickers
ACHC
AEM
AGL
ALHC
Tags
EDIT
APLS
Upgrades
From
Benzinga
10 Biggest Price Target Changes For Friday
September 10, 2021
Tickers
AFRM
ALLE
APLS
DHR
Tags
Pre/Market Outlook
Price Target Changes
DHR
From
Benzinga
3 Red-Hot Healthcare Stocks to Buy in September
September 09, 2021
Tickers
AZN
BIIB
CRSP
DHR
Tags
GE
BAYR/Y
VEEV
From
Motley Fool
< Previous
1
2
3
4
5
6
7
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.